Skip to Content

BMS 215 (Daklinza 60 mg)

Generic Name: daclatasvir

Pill with imprint BMS 215 is Green, Five-sided and has been identified as Daklinza 60 mg. It is supplied by Bristol-Myers Squibb Company.

Daklinza is used in the treatment of hepatitis c and belongs to the drug class NS5A inhibitors. Daklinza 60 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 215

Daklinza

Generic Name
daclatasvir
Imprint
BMS 215
Strength
60 mg
Color
Green
Shape
Five-sided
Availability
Prescription only
Drug Class
NS5A inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb Company
National Drug Code (NDC)
00003-0215

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.